Trial Details

TERMINATED
Basic Information
Clinical ID c1231
Identifier NCT02808390
Trial Title Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: GED-0507-34-Levo 80 mg|DRUG: GED-0507-34-Levo 160 mg|DRUG: Placebo
Participant Information
Sponsor PPM Services S.A.
City San Diego
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2016-11-28
Primary Completion Date 2017-07-31
Completion Date 2017-07-31